Medtech Acquisition Corp Performance
The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Medtech Acquisition are completely uncorrelated.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Medtech Acquisition Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Medtech Acquisition is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors. ...more
| Begin Period Cash Flow | 200.9 K | |
| Total Cashflows From Investing Activities | 233.2 M |
Medtech |
Medtech Acquisition Relative Risk vs. Return Landscape
If you would invest (100.00) in Medtech Acquisition Corp on November 28, 2024 and sell it today you would earn a total of 100.00 from holding Medtech Acquisition Corp or generate -100.0% return on investment over 90 days. Medtech Acquisition Corp is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded stocks are less volatile than Medtech, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Medtech Acquisition Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medtech Acquisition's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Medtech Acquisition Corp, and traders can use it to determine the average amount a Medtech Acquisition's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| MTACU |
Based on monthly moving average Medtech Acquisition is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Medtech Acquisition by adding Medtech Acquisition to a well-diversified portfolio.
Medtech Acquisition Fundamentals Growth
Medtech Stock prices reflect investors' perceptions of the future prospects and financial health of Medtech Acquisition, and Medtech Acquisition fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Medtech Stock performance.
| Return On Asset | -0.0193 | |||
| Current Valuation | 81.09 M | |||
| Price To Earning | 39.61 X | |||
| EBITDA | (8.58 M) | |||
| Cash And Equivalents | 69.18 K | |||
| Total Debt | 2.37 M | |||
| Debt To Equity | 1.77 % | |||
| Book Value Per Share | (2.42) X | |||
| Cash Flow From Operations | (2.74 M) | |||
| Earnings Per Share | 0.26 X | |||
| Total Asset | 20.19 M | |||
| Retained Earnings | (13.27 M) | |||
Things to note about Medtech Acquisition Corp performance evaluation
Checking the ongoing alerts about Medtech Acquisition for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Medtech Acquisition Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Medtech Acquisition is not yet fully synchronised with the market data | |
| Medtech Acquisition has some characteristics of a very speculative penny stock | |
| Medtech Acquisition has a very high chance of going through financial distress in the upcoming years | |
| Medtech Acquisition Corp has accumulated 2.37 M in total debt with debt to equity ratio (D/E) of 1.77, which is about average as compared to similar companies. Medtech Acquisition Corp has a current ratio of 0.15, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about Medtech Acquisition's use of debt, we should always consider it together with its cash and equity. | |
| Medtech Acquisition Corp has accumulated about 69.18 K in cash with (2.74 M) of positive cash flow from operations. |
- Analyzing Medtech Acquisition's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Medtech Acquisition's stock is overvalued or undervalued compared to its peers.
- Examining Medtech Acquisition's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Medtech Acquisition's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Medtech Acquisition's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Medtech Acquisition's stock. These opinions can provide insight into Medtech Acquisition's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Consideration for investing in Medtech Stock
If you are still planning to invest in Medtech Acquisition Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medtech Acquisition's history and understand the potential risks before investing.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |